Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma

Despite advances in the treatment of cancers through surgical procedures and new pharmaceuticals, the treatment of hepatocellular carcinoma (HCC) remains challenging as reflected by low survival rates. The PI3K/Akt/mTOR pathway is an important signaling mechanism that regulates the cell cycle, proli...

Full description

Saved in:
Bibliographic Details
Main Authors: Eun Jin Sun, Miriam Wankell, Pranavan Palamuthusingam, Craig McFarlane, Lionel Hebbard
Format: article
Language:EN
Published: MDPI AG 2021
Subjects:
HCC
Akt
Online Access:https://doaj.org/article/89bb6a0c34c4433e8753a977ce9ed1e1
Tags: Add Tag
No Tags, Be the first to tag this record!